Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3708306018 | Product containing abacavir and lamivudine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3708307010 | Abacavir- and lamivudine-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Is a | Product containing abacavir and lamivudine (medicinal product) | true | Inferred relationship | Some | ||
| Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Is a | Abacavir-containing product in oral dose form | true | Inferred relationship | Some | ||
| Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Has active ingredient | Lamivudine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Has active ingredient | Abacavir (substance) | true | Inferred relationship | Some | 2 | |
| Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Is a | Lamivudine-containing product in oral dose form | true | Inferred relationship | Some | ||
| Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| abacavirsulfat 300 mg + lamivudin 150 mg + zidovudin 300 mg tablet | Is a | False | Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Inferred relationship | Some | |
| abacavir 600 mg + lamivudin 300 mg tablet | Is a | False | Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing abacavir and dolutegravir and lamivudine in oral dose form (medicinal product form) | Is a | True | Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing abacavir and lamivudine and zidovudine in oral dose form (medicinal product form) | Is a | True | Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Abacavir and lamivudine only product in oral dose form | Is a | True | Product containing abacavir and lamivudine in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR